Seroprevalence of HBsAg, HCV and HIV among antenatal women at a tertiary care centre in Northern India: a cross-sectional study from SNMC Agra

Authors

  • Itishree Jena Department of Obstetrics and Gynecology, SNMC, Agra, Uttar Pradesh, India
  • Urvashi Verma Department of Obstetrics and Gynecology, SNMC, Agra, Uttar Pradesh, India
  • Ruchika Garg Department of Obstetrics and Gynecology, SNMC, Agra, Uttar Pradesh, India
  • Meenal Jain Department of Obstetrics and Gynecology, SNMC, Agra, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20262523

Keywords:

HBsAg, HCV, HIV, Pregnancy, Seroprevalence

Abstract

Background: Blood-borne viral infections such as hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) significantly affect maternal health and pose a risk of vertical transmission. Antenatal screening is crucial for early detection and prevention. To determine the seroprevalence of HBsAg, anti-HCV and HIV among antenatal women attending a tertiary care centre.

Methods: A cross-sectional study was conducted from September 2023 to August 2024 among 314 antenatal women at SNMC Agra. Blood samples were tested using standard rapid immunochromatographic methods as per NACO guidelines.

Results: Among 314 women, 104 (33.1%) were reactive for at least one viral marker. HBsAg prevalence was 14.3%, HCV 10.5% and HIV 8.3%.

Conclusions: A high prevalence of viral infections highlights the need for universal antenatal screening and strengthened preventive strategies.

References

World Health Organization. Global hepatitis report. 2017.

World Health Organization. HIV global statistics. 2023.

Jiles RB, Barker LK, Ly KN, Kloc N, DeMaria Jr A. Viral Hepatitis Surveillance in the United States: Then, Now, and Looking Forward. Public Health Reports. 2025:3:367.

Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of viral hepatitis. Lancet Glob Health. 2014;2:646-54.

Terrault NA, Levy MT, Cheung KW, Jourdain G. HBV infection in pregnancy. Hepatology. 2018;67:422-38.

Ghany MG, Morgan TR, Afdhal NH, Doo E, Dienstag JL, Hoofnagle JH, et al. Hepatitis C guidance 2019 update: AASLD-IDSA recommendations. J Hepatol. 2020;73:123-35.

UNAIDS. Global HIV and AIDS statistics - Fact sheet 2023. Geneva: UNAIDS. 2023.

Khokhar N, Gill ML, Malik GJ, Ahmad F, Ahmad MA, Khokhar OS. General seroprevalence of hepatitis C and hepatitis B virus infections. Int J Curr Microbiol App Sci. 2015;4(9):188-94.

Singh A, Shrivastava C, Thakur A. Prevalence of HBsAg in antenatal women. Indian J Med Microbiol. 2020;38:45-9.

Mehta KD, Antala S, Mistry M, Goswami Y. Seropositivity of hepatitis B, C, syphilis and HIV in antenatal women in India. J Clin Diagn Res. 2017;11:13-6.

Arora U, Bal A, Aggarwal A, Sharma A, Rohilla M, Jain S. HCV seroprevalence among blood donors in North India. Indian J Med Res. 2019;150:553-60.

Patel P, Shringarpure K, Bhavsar BS, Patel M, Patel A, Sinha M. HIV trends in antenatal clinic attendees in Gujarat, India. Indian J Community Med. 2018;43:159-64.

World Health Organization SEARO. Hepatitis B and C epidemiology in India. New Delhi: WHO SEARO. 2022.

National AIDS Control Organization. India HIV Estimations 2023: Technical Report. New Delhi: NACO, Ministry of Health and Family Welfare; 2023.

Oti BV, Ankrah DA, Danso EK, Adjei EN, Boateng KB, Bonney EY. Seroprevalence of HBsAg and HCV among pregnant women. Hepatol Pancreat Sci. 2018;2:1-4.

Shaikh F, Noorani M, Abbas Z, Siddiqui AR. HCV in pregnancy: Seroprevalence and risk factors. Gomal J Med Sci. 2009;7:86-8.

Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women in Northern Uganda. BMJ Open. 2014;4:5889.

Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence and predictors of hepatitis B infection in a low-resource setting. Virol J. 2011;8:12.

Sharma R, Mathur A, Kumar M, Patil S, Sharma N. Seroprevalence of viral hepatitis B, C and HIV among antenatal women. Int J Obstet Gynaecol Res. 2021;10:202-7.

Lalman L, Chandraprabha T, Vijayalakshmi P, Maheswari KS. Viral markers among antenatal women. IP Int J Med Microbiol Trop Dis. 2021;7:242-5.

Downloads

Published

2026-07-29

How to Cite

Jena, I., Verma, U., Garg, R., & Jain, M. (2026). Seroprevalence of HBsAg, HCV and HIV among antenatal women at a tertiary care centre in Northern India: a cross-sectional study from SNMC Agra. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 15(8), 2995–2998. https://doi.org/10.18203/2320-1770.ijrcog20262523

Issue

Section

Original Research Articles